MedTrace Logo

Gene Therapy in Treating Patients With Cancer

NCT00004178 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2011-06-10

No results posted yet for this study

Summary

RATIONALE: Inserting a gene that has been created in the laboratory into a person's white blood cells may make the body build an immune response to kill cancer cells.

PURPOSE: Phase I trial to study the effectiveness of gene therapy in treating patients who have cancer that has not responded to previous therapy.

Conditions

Interventions

BIOLOGICAL

therapeutic autologous lymphocytes

Sponsors & Collaborators

Principal Investigators

  • Richard P. Junghans, MD, PhD · Beth Israel Deaconess Medical Center

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-04-30
Primary Completion
2000-12-31
Completion
2001-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004178 on ClinicalTrials.gov